Article Information
Volume 79, Issue 3, pp. 467-481
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 15, 2017
- Revision received April 11, 2018
- Accepted November 16, 2018
- Published first February 1, 2019.
Article Versions
- Previous version (November 28, 2018 - 07:09).
- Previous version (January 24, 2019 - 06:23).
- You are viewing the most recent version of this article.
Copyright & Usage
©2018 American Association for Cancer Research.
Author Information
- Melissa A. Buckley1,2,
- Nicholas T. Woods1,3,
- Jonathan P. Tyrer4,
- Gustavo Mendoza-Fandiño1,
- Kate Lawrenson5,
- Dennis J. Hazelett6,7,8,
- Hamed S. Najafabadi9,10,
- Anxhela Gjyshi1,2,
- Renato S. Carvalho1,
- Paulo C. Lyra Jr1,
- Simon G. Coetzee8,
- Howard C. Shen6,
- Ally W. Yang9,
- Madalene A. Earp11,
- Sean J. Yoder12,
- Harvey Risch13,
- Georgia Chenevix-Trench14,
- Susan J. Ramus15,16,
- Catherine M. Phelan1,†,
- Gerhard A. Coetzee6,17,
- Houtan Noushmehr18,
- Timothy R. Hughes9,19,20,
- Thomas A. Sellers1,
- Ellen L. Goode11,
- Paul D. Pharoah4,
- Simon A. Gayther5,21, and
- Alvaro N.A. Monteiro1,*; on behalf of the Ovarian Cancer Association Consortium
- 1Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
- 2University of South Florida Cancer Biology PhD Program, Tampa, Florida.
- 3Department of Oncological Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida.
- 4The Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
- 5Women's Cancer Program at the Samuel Oschin Comprehensive, Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
- 6Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.
- 7Department of Urology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California.
- 8Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
- 9Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
- 10Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
- 11Division of Biomedical Statistics and Informatics, Department of Health Science Research, Mayo Clinic, Rochester, Minnesota.
- 12Molecular Genomics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
- 13Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.
- 14QIMR Berghofer Medical Research Institute, Brisbane, Australia.
- 15School of Women's and Children's Health, University of New South Wales, Sydney, Australia.
- 16The Kinghorn Cancer Center, Garvan Institute of Medical Research, Darlinghurst, Australia.
- 17Van Andel Institute, Grand Rapids, Michigan.
- 18Department of Neurosurgery, Henry Ford Health System, Detroit, Michigan.
- 19Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
- 20Canadian Institutes for Advanced Research, Toronto, Ontario, Canada.
- 21Center for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
- ↵*Corresponding Author:
Alvaro N.A. Monteiro, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612. Phone: 813-745-6321; Fax: 813-903-6847; E-mail: alvaro.monteiro{at}moffitt.org
February 2019
Volume 79, Issue 3
Volume 79, Issue 3
Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus
Jump to section
Advertisement